How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The AI effect in ...

Zantac was originated by GSK and launched by ... along with a class action in Israel. The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma ...

The effects of PPIs last longer than those of H2 ... Here are a few important ones to keep in mind: In 2020, the H2 blocker ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Zantac 360 Famotidine may also be used for purposes ... using this medicine if you are pregnant or breastfeeding. Some side effects may be more likely in older adults and in people who have ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.

GSK PLC (GSK) reports robust year-to-date sales growth, driven by Specialty Medicines, while navigating vaccine sales ...